Community-Acquired Pneumonia (CAP) Clinical Trial
Official title:
A Phase 2, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of RX-1741 in the Treatment of Adult Patients With Mild to Moderate Severity of Community-Acquired Pneumonia (CAP)
The purpose of this study is to determine whether RX-1741, an oxazolidinone antibiotic, is safe and effective in the treatment of mild to moderate community acquired pneumonia (CAP).
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03208361 -
Efficacy of High Doses Penicillin V Versus High Doses Amoxicillin in the Treatment of Non-severe Pneumonia.
|
Phase 3 | |
| Completed |
NCT03439124 -
Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia
|
Phase 3 | |
| Completed |
NCT00035347 -
Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia
|
Phase 4 | |
| Completed |
NCT01130883 -
Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR
|
N/A |